PMA
CVS icon

Prudent Man Advisors’s CVS Health CVS Stock Holding History

Prudent Man Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,982
Closed -$530K – 186
2024
Q2 		$530K Buy
8,982
+349
+4% +$21.8K 0.19% 112
2024
Q1 		$689K Sell
8,633
-17
-0.2% -$1.3K 0.26% 94
2023
Q4 		$683K Sell
8,650
-497
-5% -$35.4K 0.25% 88
2023
Q3 		$639K Hold
9,147
– – 0.25% 92
2023
Q2 		$632K Sell
9,147
-163
-2% -$11.6K 0.24% 93
2023
Q1 		$692K Sell
9,310
-195
-2% -$16.4K 0.27% 82
2022
Q4 		$886K Sell
9,505
-111
-1% -$10.7K 0.36% 61
2022
Q3 		$917K Sell
9,616
-1,441
-13% -$143K 0.43% 42
2022
Q2 		$1.02M Sell
11,057
-116
-1% -$11.3K 0.48% 38
2022
Q1 		$1.13M Sell
11,173
-165
-1% -$17.3K 0.46% 43
2021
Q4 		$1.17M Sell
11,338
-1,995
-15% -$184K 0.45% 46
2021
Q3 		$1.13M Buy
+13,333
New +$1.12M 0.43% 49

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Prudent Man Advisors's CVS Position: Q3 2024 in Review

Prudent Man Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 8,982 shares — an estimated $530K sold.

Prudent Man Advisors first reported a position in CVS in Q3 2021 and held it in 12 quarters. The position peaked at $1.17M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Prudent Man Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Prudent Man Advisors sold 8,982 CVS Health shares in Q3 2024, an estimated $530K.
  • Prudent Man Advisors first reported a position in CVS Health in Q3 2021 and held it in 12 quarters.
  • Prudent Man Advisors's CVS Health position peaked at $1.17M in Q4 2021.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Prudent Man Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.